Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Summary of Grant-date Fair Value of Stock Options Granted

The assumptions that the Company used to determine the grant-date fair value of stock options granted were as follows, presented on a weighted-average basis:

	Year Ended December 31,
	2022			2021
Expected option life (years)		6.1			5.6
Risk-free interest rate		3.37	%		0.90	%
Expected volatility		64.20	%		62.84	%
Expected dividend yield		—	%		—	%

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the year ended December 31, 2022:

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2021		2,689,935		$	0.59			$	767
Granted		984,200			2.96
Exercised		(1,385,310	)		0.59
Cancelled or forfeited		(136,184	)		0.59
Outstanding as of December 31, 2022		2,152,641		$	1.67		9.1	$	748
Exercisable as of December 31, 2022		484,444		$	0.59		8.5	$	310

Summary of Stock-based Compensation Expense

Stock-based compensation expense was allocated as follows:

	Year Ended December 31,
	2022		2021
Cost of revenue	$	1,776	$	19,876
Research and development		11,608		414,322
General and administrative		362,406		680,458
Total stock-based compensation	$	375,790	$	1,114,656